Invested in innovation

Pathwork Diagnostics' business model is based on high-value molecular tests in oncology, with a focused strategy for commercialization and a promising product pipeline. We work closely with these investors, who share our commitment to innovations that contribute to better patient care.

Abingworth

Abingworth is an international group dedicated to investment in the life sciences and healthcare industries.

Prospect

Prospect Venture Partners invests in biomedical enterprises that offer entrepreneurial management teams, proprietary products, and innovative technologies.

Advent

Advent Venture Partners has backed more than 200 companies, with a focus on early- and late-stage development in the life sciences and technology.

Novus Ventures

Novus Ventures seeks new ventures in information technology, supporting enterprise software, infrastructure, and intellectual property firms.

Venrock

Venrock is the venture capital enterprise of the Rockefeller family, providing funding for breakthrough ideas in technology, healthcare, media, and energy.

Versant

Versant Ventures provides early-stage investment in medical devices, biotechnology, pharmaceuticals, and healthcare information technology.

Privacy statement  |   Terms and Conditions  |   © 2010 Pathwork Diagnostics, Inc.